Clinically, MMR‐deficient UTUC tends to present at a younger age and an early stage and is histologically classified as a low‐grade tumor with distinct pathological features [8, 9, 10]. This evidence concerns the gene MRC1 and renal pelvis/ureter urothelial carcinoma.